Inozyme Pharma, Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit: ratio: %
Description: The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary: Inozyme Pharma, Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
Inozyme Pharma, Inc. Current Ratio for the quarter ending September 30, 2024 was 1.09K %, a 7.73% decline year-over-year.

Current Ratio, Quarterly (%)

Current Ratio, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	1.09K	-91.2	-7.73%	Sep 30, 2024
Q2 2024	1.32K	+262	+24.8%	Jun 30, 2024
Q1 2024	1.39K	+282	+25.4%	Mar 31, 2024
Q4 2023	1.31K	+258	+24.6%	Dec 31, 2023
Q3 2023	1.18K	+97.7	+9.02%	Sep 30, 2023
Q2 2023	1.06K	-95.4	-8.28%	Jun 30, 2023
Q1 2023	1.11K	-116	-9.5%	Mar 31, 2023
Q4 2022	1.05K	-507	-32.6%	Dec 31, 2022
Q3 2022	1.08K	-661	-37.9%	Sep 30, 2022
Q2 2022	1.15K	-646	-35.9%	Jun 30, 2022
Q1 2022	1.22K	-358	-22.6%	Mar 31, 2022
Q4 2021	1.56K			Dec 31, 2021
Q3 2021	1.74K			Sep 30, 2021
Q2 2021	1.8K			Jun 30, 2021
Q1 2021	1.58K			Mar 31, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.